ArticleClinical rheumatology2025
Evaluation of the coalescent lung ultrasound score in rheumatoid arthritis-associated interstitial lung disease.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI-based CT quantification reveals small airway loss and vascular simplification in rheumatoid arthritis-associated lung disease.Clinical rheumatology · 2026Article
- Diagnostic value of lung ultrasound in interstitial lung disease associated with rheumatoid arthritis: Correlation with HRCT and differentiation of ILD subtypes.Rheumatology and immunology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveRheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that can present with extra-articular findings. RA-associated interstitial lung disease (RA-ILD) is the most prominent extra-articular finding and is important because it contributes significantly to morbidity and mortality. The aim of this study was to determine the role of lung ultrasonography (LUS) in diagnosing RA-ILD and assessing the severity of involvement.
methodThe study included 69 patients aged 18 years and older who met the ACR/EULAR 2010 RA classification criteria. LUS was performed on the patients by an experienced, blinded specialist and the findings were compared with the high-resolution computed tomography (HRCT) Warrick score evaluated by an experienced radiologist.
resultsA statistically significant correlation was found between modified LUS scores and Warrick scores (r: 0.838). Among the patients screened with USG, USG ILD findings were detected in 35 patients with RA-ILD diagnosis (100%) and 1 of the 34 controls (2.9%). LUS was false positive in only 1 RA patient (p < 0.001).
conclusionIn conclusion, USG can be considered as a method correlated with CT in assessing the degree of lung involvement. However, USG cannot distinguish malignant nodules, infectious disease or drug adverse reactions. HRCT is a reliable method for the primary differential diagnosis of lung involvement. According to our study, LUS can prolong the CT scan intervals in patients with stable clinical conditions and no obvious symptoms, thereby reducing unnecessary radiation exposure. Key Points • RA with interstitial lung disease • LUS in interstitial lung disease.
Indexed as
Identifiers
40707847What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.